StockData
Zoetis Inc. logo

Zoetis Inc. (ZTS) stock

ZTSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 17/3043% below fair value
$80.79−4.78 (-5.59%)

Close on Nov 19, 2026Market cap $33.38BP/E 13.3Yield 2.51%

Zoetis net income

Net income is the profit left for shareholders after every expense, interest and tax.

Zoetis's net income for the twelve months ending Jun 30, 2026 was $2.62B, up 1.0% year over year. For fiscal 2025 it was $2.67B, up 7.5% from the year before. Over ten years it grew 22.9% a year on average. The highest annual figure on record is $2.67B in fiscal 2025.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.67B+7.5%
FY2024Dec 31, 2024$2.49B+6.1%
FY2023Dec 31, 2023$2.34B+10.9%
FY2022Dec 31, 2022$2.11B+3.8%
FY2021Dec 31, 2021$2.04B+24.4%
FY2020Dec 31, 2020$1.64B+9.2%
FY2019Dec 31, 2019$1.50B+5.0%
FY2018Dec 31, 2018$1.43B+65.3%
FY2017Dec 31, 2017$864.00M+5.2%
FY2016Dec 31, 2016$821.00M+142.2%
FY2015Dec 31, 2015$339.00M-41.9%
FY2014Dec 31, 2014$583.00M+15.7%
FY2013Dec 31, 2013$504.00M+15.6%
FY2012Dec 31, 2012$436.00M+78.0%
FY2011Dec 31, 2011$245.00M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$691.00M-4.8%
Q1 FY2026Mar 31, 2026$601.00M-0.2%
Q4 FY2025Dec 31, 2025$603.00M+3.8%
Q3 FY2025Sep 30, 2025$721.00M+5.7%
Q2 FY2025Jun 30, 2025$726.00M+16.3%
Q1 FY2025Mar 31, 2025$602.00M+0.5%
Q4 FY2024Dec 31, 2024$581.00M+10.7%
Q3 FY2024Sep 30, 2024$682.00M+14.4%
Q2 FY2024Jun 30, 2024$624.00M-7.0%
Q1 FY2024Mar 31, 2024$599.00M+8.5%
Q4 FY2023Dec 31, 2023$525.00M+13.9%
Q3 FY2023Sep 30, 2023$596.00M+12.7%
Q2 FY2023Jun 30, 2023$671.00M+26.8%
Q1 FY2023Mar 31, 2023$552.00M-7.2%
Q4 FY2022Dec 31, 2022$461.00M+11.4%
Q3 FY2022Sep 30, 2022$529.00M-4.2%
Q2 FY2022Jun 30, 2022$529.00M+3.3%
Q1 FY2022Mar 31, 2022$595.00M+6.4%
Q4 FY2021Dec 31, 2021$414.00M+15.3%
Q3 FY2021Sep 30, 2021$552.00M+15.2%
Q2 FY2021Jun 30, 2021$512.00M+35.8%
Q1 FY2021Mar 31, 2021$559.00M+32.2%
Q4 FY2020Dec 31, 2020$359.00M-6.5%
Q3 FY2020Sep 30, 2020$479.00M+10.6%
Q2 FY2020Jun 30, 2020$377.00M+1.6%
Q1 FY2020Mar 31, 2020$423.00M+35.6%
Q4 FY2019Dec 31, 2019$384.00M+11.3%
Q3 FY2019Sep 30, 2019$433.00M+24.8%
Q2 FY2019Jun 30, 2019$371.00M-3.4%
Q1 FY2019Mar 31, 2019$312.00M-11.4%
Q4 FY2018Dec 31, 2018$345.00M+325.9%
Q3 FY2018Sep 30, 2018$347.00M+16.4%
Q2 FY2018Jun 30, 2018$384.00M+55.5%
Q1 FY2018Mar 31, 2018$352.00M+47.9%
Q4 FY2017Dec 31, 2017$81.00M-47.4%
Q3 FY2017Oct 1, 2017$298.00M+24.7%
Q2 FY2017Jul 2, 2017$247.00M–
Q1 FY2017Apr 2, 2017$238.00M–
Q4 FY2016Dec 31, 2016$154.00M–
Q3 FY2016Oct 2, 2016$239.00M–

More Zoetis figures

See a number that looks wrong?